Axonics (AXNX) Announces FDA Approval for its Sacral Neuromodulation System for Urinary Clinical Indications

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Axonics (AXNX) Announces FDA Approval for its Sacral Neuromodulation System for Urinary Clinical Indications
(NASDAQ: AXNX) Delayed: 70.98 --0 (-0%)
Previous Close $70.98    52 Week High $ 
Open $70.98    52 Week Low $ 
Day High $70.98    P/E N/A 
Day Low $70.98    EPS $ 
Volume 147